Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
CMND
CMND News & Events
-
Add to Watchlist
Trade CMND
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
CMND News
Clearmind's Positive Clinical Trial Results May Support Breakthrough Therapy Designation
Apr 27 2026
Newsfilter
CLEARMIND MEDICINE INC - HAS NOT APPLIED FOR OR BEEN GRANTED FDA BREAKTHROUGH THERAPY DESIGNATION FOR MEAI
Apr 27 2026
moomoo
Clearmind Medicine Reports Positive Clinical Trial Results and Regulatory Support
Apr 21 2026
NASDAQ.COM
Trump Signs Executive Order to Accelerate Psychedelic Research
Apr 20 2026
stocktwits
Clearmind's Drug Clinical Trial Achieves Success
Apr 20 2026
Newsfilter
Trump Administration to Examine Safety of Psychedelic Drug for PTSD
Apr 18 2026
Yahoo Finance
Trump Administration to Examine Ibogaine Research for PTSD Funding
Apr 16 2026
stocktwits
Clearmind Medicine's CMND-100 Trial Receives Positive DSMB Recommendation
Apr 16 2026
NASDAQ.COM
Show More News
CMND Events
05/05 09:00
Clearmind Medicine Files European Patent Application
Clearmind Medicine announced the filing of a European patent application for innovative psychedelic compounds targeting the treatment of Post-Traumatic Stress Disorder and other mental health disorders.
04/30 16:41
Clearmind Medicine Files to Sell 22.63M Common Shares
Clearmind Medicine files to sell 22.63M common shares for holders
04/27 07:50
Clearmind Medicine Evaluates CMND-100 for FDA Breakthrough Therapy Designation
Clearmind Medicine announced that it is evaluating CMND-100, for eligibility for the FDA's breakthrough therapy designation.
Show More Events
CMND Monitor News
Clearmind Medicine's CMND-100 Shows Promise for Breakthrough Therapy Designation
May 01 2026
Clearmind's CMND-100 Drug Trial Achieves Key Safety Milestone
Apr 27 2026
Clearmind's CMND-100 Drug Trial Achieves Key Safety Milestone
Apr 22 2026
Clearmind's CMND-100 Trial Shows Positive Results Amid Market Volatility
Apr 21 2026
Clearmind's CMND-100 Drug Trial Achieves Key Safety Milestone
Apr 20 2026
Clearmind's CMND-100 Trial Achieves Key Milestone
Apr 16 2026
Clearmind Medicine's CMND-100 Trial Shows Positive Results
Apr 15 2026
Clearmind Medicine Inc. reaches 20-day high amid market gains
Apr 14 2026
Show More Monitor News
CMND Earnings Analysis
No Data
People Also Watch
